Adult-onset Still Disease
📧 Sign up to get email alerts when something new happens for Adult-onset Still Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD [Phase 3]
Phase 3 study evaluated the efficacy and safety of canakinumab in Japanese adults with Adult Onset Still's Disease. Results have been posted…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE [Phase 3]
A Phase 3 clinical trial evaluated the efficacy, safety, tolerability, and pharmacokinetics/pharmacodynamics of emapalumab in children and a…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Assessment of Macrophage Activation syndromE in STill's Disease in Italy
A clinical trial evaluating macrophage activation syndrome in Still's disease (systemic juvenile idiopathic arthritis and adult-onset Still'…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease [Phase 3]
A Phase 3 efficacy and safety trial evaluating GNR-086 (canakinumab biosimilar) versus Ilaris (canakinumab) in adults with adult-onset Still…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Assessment of Macrophage Activation syndromE in STill's Disease
A completed clinical trial assessing macrophage activation syndrome in Still's disease, including adult-onset Still's disease and juvenile-o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Canakinumab for Treatment of Adult-onset Still's Disease [Phase 2]
Phase 2 trial update on canakinumab for adult-onset Still's disease (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study [Phase 2]
A randomized Phase 2 trial evaluated the efficacy and safety of anakinra for refractory adult-onset Still's disease. The study status indica…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease [Phase 2]
A Phase 2 clinical trial evaluating Tadekinig alfa for adult-onset Still's disease has completed, providing updated results.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Interleukin-1 Trap to Treat Autoinflammatory Diseases [Phase 2]
Phase 2 trial evaluating an Interleukin-1 trap for autoinflammatory diseases completed, with results posted in 2013, including Familial Medi…
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: Efficacy and Safety of Tocilizumab in Adult's Still Disease [Phase 2]
This clinical trial update reports Phase 2 results evaluating the efficacy and safety of tocilizumab in adults with adult-onset Still's dise…